News

31. INTERPHEX Announces Show Floor Tour Options In Partnership With Parenteral Drug Association And CRB Group 1/9/2025

    INTERPHEX is excited to announce a new initiative to create dynamic and interactive opportunities for a broader range of attendees. Based on valuable insights from customer surveys and the INTERPHEX Attendee Advisory Committee, we are introducing reimagined Show Floor Tour options that focus on diverse industry themes. These tours are designed to maximize attendee engagement and ensure more meaningful exploration of the show floor. To bring these ideas together, INTERPHEX has partnered with CRB Group and PDA for their industry expertise.

32. Ultrasound System Can Remove Common Plastic Pollutant From Water 8/6/2025

    Researchers at a Scottish university have found a new way to remove a common pollutant from water using controlled waves of ultrasound, without the use of additional chemicals.

33. Stoichiometric Crystal Shows Promise In Quantum Memory 7/7/2025

    For over two decades, physicists have been working toward implementing quantum light storage—also known as quantum memory—in various matter systems.

34. Researchers Glimpse The Inner Workings Of Protein Language Models 8/18/2025

    Within the past few years, models that can predict the structure or function of proteins have been widely used for a variety of biological applications, such as identifying drug targets and designing new therapeutic antibodies.

35. GD Energy Products' Y-Shaped Drilling Module Now Rated For 10,000 PSI 8/18/2025

    GD Energy Products (GDEP), the leading total solutions provider for the frac, drilling and well servicing pumps market, has announced its patented Y-Shaped Drilling Module is now rated for operating pressures up to 10,000 psi.

36. Silo Pharma Expands Intellectual Property Portfolio With Patent Application For Exclusively Licensed Alzheimer's Drug 4/28/2025

    Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced the filing of a patent application with the U.S. Patent and Trademark Office (USPTO) focused on the neurology drug SPC-14, an intranasal compound for the treatment of Alzheimer’s disease (AD) exclusively licensed to Silo Pharma from Columbia University.

37. NKT Photonics Fiber Lasers Enable Groundbreaking Deep-Space Communication 7/16/2025

    On July 7, ESA, the European Space Agency, successfully established Europe’s first deep-space optical communication link with NASA’s Psyche mission using a high-power fiber laser system from NKT Photonics.

38. Giant Radar Antenna Reflector On NASA-ISRO Satellite In Full 'Bloom' 8/15/2025

    Spanning 39 feet (12 meters), the drum-shaped antenna reflector on the NISAR (NASA-ISRO Synthetic Aperture Radar) satellite mission from NASA and the Indian Space Research Organisation (ISRO) successfully unfurled in low Earth orbit.

39. AEON Biopharma Appoints Industry Veteran Rob Bancroft As Chief Executive Officer 4/21/2025

    AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex for the treatment of multiple therapeutic indications, announced today the appointment of Rob Bancroft as President and Chief Executive Officer, effective April 29, 2025. Mr. Bancroft will also join AEON’s Board of Directors.

40. Shell Expands Gulf Of America Leadership Position With Dover Development 4/8/2025

    Shell Offshore Inc. (Shell), a subsidiary of Shell plc, today announced the start of production at Dover, the second subsea tieback connecting new wells to the existing infrastructure of the Shell-operated Appomattox production hub in the Gulf of America.